314 related articles for article (PubMed ID: 8666141)
1. MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice.
Serreze DV; Gallichan WS; Snider DP; Croitoru K; Rosenthal KL; Leiter EH; Christianson GJ; Dudley ME; Roopenian DC
Diabetes; 1996 Jul; 45(7):902-8. PubMed ID: 8666141
[TBL] [Abstract][Full Text] [Related]
2. Crosses of NOD mice with the related NON strain. A polygenic model for IDDM.
McAleer MA; Reifsnyder P; Palmer SM; Prochazka M; Love JM; Copeman JB; Powell EE; Rodrigues NR; Prins JB; Serreze DV
Diabetes; 1995 Oct; 44(10):1186-95. PubMed ID: 7556956
[TBL] [Abstract][Full Text] [Related]
3. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience.
Choisy-Rossi CM; Holl TM; Pierce MA; Chapman HD; Serreze DV
J Immunol; 2004 Sep; 173(6):3791-800. PubMed ID: 15356126
[TBL] [Abstract][Full Text] [Related]
4. Reevaluation of the major histocompatibility complex genes of the NOD-progenitor CTS/Shi strain.
Mathews CE; Graser RT; Serreze DV; Leiter EH
Diabetes; 2000 Jan; 49(1):131-4. PubMed ID: 10615961
[TBL] [Abstract][Full Text] [Related]
5. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.
Lee MS; Mueller R; Wicker LS; Peterson LB; Sarvetnick N
J Exp Med; 1996 Jun; 183(6):2663-8. PubMed ID: 8676087
[TBL] [Abstract][Full Text] [Related]
6. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
7. Subcongenic analysis of the Idd13 locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for beta 2-microglobulin.
Serreze DV; Bridgett M; Chapman HD; Chen E; Richard SD; Leiter EH
J Immunol; 1998 Feb; 160(3):1472-8. PubMed ID: 9570569
[TBL] [Abstract][Full Text] [Related]
8. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions.
Graser RT; DiLorenzo TP; Wang F; Christianson GJ; Chapman HD; Roopenian DC; Nathenson SG; Serreze DV
J Immunol; 2000 Apr; 164(7):3913-8. PubMed ID: 10725754
[TBL] [Abstract][Full Text] [Related]
9. Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8+ T cells in nonobese diabetic mice.
Serreze DV; Choisy-Rossi CM; Grier AE; Holl TM; Chapman HD; Gahagan JR; Osborne MA; Zhang W; King BL; Brown A; Roopenian D; Marron MP
J Immunol; 2008 Mar; 180(5):3250-9. PubMed ID: 18292549
[TBL] [Abstract][Full Text] [Related]
10. Elimination of self-peptide major histocompatibility complex class I reactivity in NOD and beta 2-microglobulin-negative mice.
Huang R; Guo J; Li X; Faustman DL
Diabetes; 1995 Sep; 44(9):1114-20. PubMed ID: 7657037
[TBL] [Abstract][Full Text] [Related]
11. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
Quinn A; McInerney MF; Sercarz EE
J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
[TBL] [Abstract][Full Text] [Related]
12. Influence on spontaneous tissue inflammation by the major histocompatibility complex region in the nonobese diabetic mouse.
Lindqvist AK; Nakken B; Sundler M; Kjellén P; Jonsson R; Holmdahl R; Skarstein K
Scand J Immunol; 2005 Feb; 61(2):119-27. PubMed ID: 15683448
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
14. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
Serreze DV; Gaskins HR; Leiter EH
J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
[TBL] [Abstract][Full Text] [Related]
15. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
Lobigs M; Müllbacher A
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2676-80. PubMed ID: 8464875
[TBL] [Abstract][Full Text] [Related]
16. The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice.
Wong FS; Du W; Thomas IJ; Wen L
Diabetes; 2005 Jul; 54(7):2032-40. PubMed ID: 15983204
[TBL] [Abstract][Full Text] [Related]
17. NOD mice have a generalized defect in their response to transplantation tolerance induction.
Markees TG; Serreze DV; Phillips NE; Sorli CH; Gordon EJ; Shultz LD; Noelle RJ; Woda BA; Greiner DL; Mordes JP; Rossini AA
Diabetes; 1999 May; 48(5):967-74. PubMed ID: 10331399
[TBL] [Abstract][Full Text] [Related]
18. Acquired allo-tolerance to major or minor histocompatibility antigens indifferently contributes to preventing diabetes development in non-obese diabetic (NOD) mice.
Carnaud C; Legrand B; Olivi M; Peterson LB; Wicker LS; Bach JF
J Autoimmun; 1992 Oct; 5(5):591-601. PubMed ID: 1418296
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant.
Serreze DV; Leiter EH; Christianson GJ; Greiner D; Roopenian DC
Diabetes; 1994 Mar; 43(3):505-9. PubMed ID: 8314025
[TBL] [Abstract][Full Text] [Related]
20. Abnormal class I assembly and peptide presentation in the nonobese diabetic mouse.
Li F; Guo J; Fu Y; Yan G; Faustman D
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11128-32. PubMed ID: 7972022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
